Akums Drugs and Pharmaceuticals Limited (NSE:AKUMS)
India flag India · Delayed Price · Currency is INR
455.00
+13.55 (3.07%)
Last updated: Oct 1, 2025, 9:15 AM IST

NSE:AKUMS Income Statement

Millions INR. Fiscal year is Apr - Mar.
Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Jun '25 Mar '25 Mar '24 Mar '23 Mar '22 Mar '21
Operating Revenue
41,23141,18241,78236,54836,71927,226
Other Revenue
29.7329.7334.823.733.2935.83
41,26141,21141,81736,57236,75227,262
Revenue Growth (YoY)
-2.48%-1.45%14.34%-0.49%34.81%-
Cost of Revenue
24,85224,99326,20423,49324,14517,343
Gross Profit
16,40816,21815,61313,07912,6079,919
Selling, General & Admin
7,5727,5736,9186,2915,3994,541
Other Operating Expenses
4,0693,9263,7933,7653,1042,424
Operating Expenses
13,20413,03411,96711,1849,4497,663
Operating Income
3,2043,1853,6461,8953,1582,256
Interest Expense
-405.21-304.07-502.51-459.73-163.38-63.88
Interest & Investment Income
249.86249.86119.9978.846.3161.44
Earnings From Equity Investments
----2.032.033.47
Currency Exchange Gain (Loss)
41.6541.6572.05-38.9326.4627.36
Other Non Operating Income (Expenses)
159.92-3.26-3,581490.16-4,883-490.62
EBT Excluding Unusual Items
3,2513,169-246.181,963-1,8131,794
Impairment of Goodwill
-----129.77-100
Gain (Loss) on Sale of Investments
-----0.77
Gain (Loss) on Sale of Assets
-1.12-1.12-3.1745.75-20.66-4.04
Asset Writedown
38.2738.271.38-722.6410.55-
Other Unusual Items
246.51246.51-204.81216.812132.16
Pretax Income
3,5343,453-452.781,503-1,9321,723
Income Tax Expense
61.6714.76-460.68524.8576.77488.26
Earnings From Continuing Operations
3,4733,4387.9978.17-2,5091,234
Minority Interest in Earnings
-57.74-56.01-48.25-29.62-16.62-7.3
Net Income
3,4153,382-40.35948.55-2,5251,227
Net Income to Common
3,4153,382-40.35948.55-2,5251,227
Shares Outstanding (Basic)
152150143143143143
Shares Outstanding (Diluted)
152150143143143143
Shares Change (YoY)
6.35%4.58%----
EPS (Basic)
22.4522.60-0.286.63-17.658.58
EPS (Diluted)
22.4522.60-0.286.63-17.658.58
Free Cash Flow
-1,9291,869-1,522-2,257478.04
Free Cash Flow Per Share
-12.8913.06-10.64-15.783.34
Gross Margin
39.77%39.35%37.34%35.76%34.30%36.38%
Operating Margin
7.77%7.73%8.72%5.18%8.59%8.28%
Profit Margin
8.28%8.21%-0.10%2.59%-6.87%4.50%
Free Cash Flow Margin
-4.68%4.47%-4.16%-6.14%1.75%
EBITDA
4,6484,5684,7882,9084,0052,880
EBITDA Margin
11.27%11.09%11.45%7.95%10.90%10.57%
D&A For EBITDA
1,4441,3831,1421,013846.75624.48
EBIT
3,2043,1853,6461,8953,1582,256
EBIT Margin
7.77%7.73%8.72%5.18%8.59%8.28%
Effective Tax Rate
1.75%0.43%-34.92%-28.34%
Revenue as Reported
41,95441,70342,12237,00936,94527,438
Advertising Expenses
-394.17389.87354.65294.51257.82
Updated Jun 30, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.